IPA suggests best practices for employee safety in pharma manufacturing during COVID-1
The document echoes general insights on preventative measures and provides a comprehensive set of best practices for the safety of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indian Pharmaceutical Alliance
‘Prices of key pharma ingredients could rise if coronavirus outbreak in China prolongs’
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates at $2,405.42 million to India in 2018-19
Pharma Budget 2020
Pharma experts share their views and insights on the impact and implications of Budget 2020
Budget 2020: Pharma Wishlist
Leaders and experts from the pharma sector share their concerns and expectations from Budget 2020
2020: Indian pharma ‘sunrise’ segment, prognosis positive for healthcare sector
Experts said improved access to medicines in India and exploring new markets while maintaining thrust in the US will help the…
IPA appoints Satish Reddy as President of IPA for 2019-2021
Dr Rajesh Jain will continue to be as the Vice President
Indian Pharmaceutical Alliance (IPA) recently announced the names of the…
The new realities in pharma R&D
It is pivotal for India’s pharma R&D playbook to evolve and become more agile and responsive with the help of technology and…
DoP to constitute a forum of pharma associations
The forum will discuss various issues concerning NPPP, DPCO and NPPA Ministry of Chemicals and Fertilizers, Department of…
Reduce GST, form a separate ministry of pharma, zones for creation of medicines: Indian pharma body…
As per a report prepared by the IPA, at its current rate of seven to eight per cent CAGR, the Indian pharmaceutical industry is…
IPA releases Vision 2030 for Indian Pharma Industry
The report is based on a research collaboration with McKinsey & Company and takes inputs from the IPA members and industry…